JEMO-PHARM A/S: Financial statements 2015
CVR: 10216109
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
JEMO-PHARM A/S (CVR 10216109) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK -2,892,000 compared with DKK -5,417,000 the year before. Equity in the 2015 report amounted to DKK 1,469,000. The solvency ratio was 4.9%.
- Profit/Loss
- DKK -2,892,000
- Equity
- DKK 1,469,000
- Total Assets
- DKK 30,244,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | - | -2.9 mio. | 1.5 mio. | - |
| 2014 | - | 3.5 mio. | -5.4 mio. | 4.4 mio. | - |
| 2013 | - | 11.8 mio. | 1.5 mio. | 9.8 mio. | - |
| 2012 | - | 11 mio. | 2.1 mio. | 8.3 mio. | - |
Official annual report
How creditworthy is JEMO-PHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
JEMO-PHARM A/S has published its annual report for 2014. Gross profit came to DKK 3,467,000, and the net result was DKK -5,417,000.
About JEMO-PHARM A/S
JEMO-PHARM A/S is a Danish company of the type Aktieselskab based in Stege, founded in 1986. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named CMA TERADATA A/S and TERADATA A/S. The management consists of Mikael Andreas Mohr. The board consists of Svend Aage Dreist Hansen (chair), Henrik Winther Olsen and Mikael Andreas Mohr. The company is owned by THE WHOLE COMPANY A/S and MAM Invest ApS. The company has 31 employees (2026). In 2025, the company reported a gross profit of DKK 11,929,000 and a net result of DKK 30,000 compared with DKK -8,629,000 the year before. Equity in the 2025 report amounted to DKK 10,041,000.